News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
485,985 Results
Type
Article (8036)
Company Profile (141)
Press Release (477903)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166739)
Career Advice (304)
Deals (25738)
Drug Delivery (7)
Drug Development (52873)
Employer Resources (14)
FDA (9760)
Job Trends (8574)
News (238194)
Policy (17898)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (492)
Accelerated approval (26)
ADA (18)
Adcomms (1)
Allergies (98)
Alliances (33161)
ALS (108)
Alzheimer's disease (985)
Antibody-drug conjugate (ADC) (283)
Approvals (10408)
Artificial intelligence (333)
ASCO (159)
Autoimmune disease (220)
Automation (29)
Bankruptcy (263)
Belgium (1)
Best Places to Work (6965)
BIO (36)
Biologics (9)
BIOSECURE Act (1)
Biosimilars (114)
BioSpace Insights (17)
Biotechnology (89)
Bispecific (1)
Bladder cancer (139)
Brain cancer (31)
Breast cancer (518)
Cancer (3758)
Cardiovascular disease (226)
Career advice (246)
Career pathing (1)
CAR-T (178)
CDC (1)
CDMO (15)
Celiac Disease (1)
Cell therapy (486)
Cervical cancer (35)
Clinical research (48043)
Collaboration (1279)
Commercialization (3)
Compensation (1533)
Complete response letters (34)
COVID-19 (764)
CRISPR (64)
C-suite (802)
Cystic fibrosis (87)
Data (5848)
Denatured (4)
Depression (106)
Dermatology (67)
Diabetes (354)
Diagnostics (4218)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (158)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (166)
Earnings (73748)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (88119)
Executive appointments (714)
FDA (12489)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (24)
Funding (945)
Gene editing (126)
Generative AI (11)
Gene therapy (333)
GLP-1 (294)
Government (957)
Grass and pollen (2)
Guidances (281)
Healthcare (9381)
Hematology (94)
HIV (55)
Huntington's disease (23)
IgA nephropathy (68)
Immunology and inflammation (106)
Immuno-oncology (61)
Indications (162)
Infectious disease (956)
Inflammatory bowel disease (128)
Inflation Reduction Act (4)
Influenza (85)
Intellectual property (261)
Interviews (42)
IPO (12389)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5209)
Licensing (18)
Liver cancer (45)
Longevity (19)
Lung cancer (542)
Lymphoma (257)
Machine learning (29)
Management (3)
Manufacturing (565)
Marketing (8)
MASH (118)
Medical affairs (2)
Medical device (8678)
Medtech (8837)
Mergers & acquisitions (14410)
Metabolic disorders (726)
mRNA (62)
Multiple sclerosis (107)
NASH (4)
Neurodegenerative disease (227)
Neuropsychiatric disorders (40)
Neuroscience (1869)
NextGen: Class of 2026 (3153)
Non-profit (848)
Obesity (231)
Opinion (10)
Ovarian cancer (161)
Pain (177)
Pancreatic cancer (206)
Parkinson's disease (206)
Partnered (12)
Patents (497)
Patient recruitment (530)
Patient selection (2)
Peanut (32)
People (41373)
Peptides (2)
Pharmaceutical (30)
Pharmacy benefit managers (9)
Phase 1 (15519)
Phase 2 (21453)
Phase 3 (14465)
Pipeline (7687)
Policy (18)
Postmarket research (1572)
Preclinical (6553)
Press Release (34)
Prostate cancer (193)
Psychedelics (7)
Radiopharmaceuticals (195)
Rare diseases (588)
Real estate (3024)
Recruiting (6)
Regenerative medicine (2)
Regulatory (14962)
Reports (23)
Research institute (585)
Resumes & cover letters (46)
Rett syndrome (42)
RNA editing (5)
RSV (48)
Schizophrenia (102)
Series A (163)
Series B (122)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (90)
Sponsored (5)
Startups (2020)
Stomach cancer (3)
Supply chain (51)
Vaccines (334)
Venture capital (17)
Weight loss (75)
Women's health (88)
Date
Today (44)
Last 7 days (283)
Last 30 days (1420)
Last 365 days (19058)
2026 (13616)
2025 (19251)
2024 (22986)
2023 (26538)
2022 (34586)
2021 (37177)
2020 (33468)
2019 (23280)
2018 (17470)
2017 (18765)
2016 (17917)
2015 (24263)
2014 (21683)
2013 (18135)
2012 (20222)
2011 (20440)
2010 (20333)
Location
Africa (229)
Alabama (77)
Alaska (2)
Arizona (310)
Arkansas (11)
Asia (17958)
Australia (2107)
California (12345)
Canada (3233)
China (544)
Colorado (496)
Connecticut (427)
Delaware (214)
Europe (24689)
Florida (1854)
Georgia (393)
Hawaii (3)
Idaho (46)
Illinois (726)
India (52)
Indiana (323)
Iowa (16)
Japan (422)
Kansas (103)
Kentucky (32)
Louisiana (27)
Maine (26)
Maryland (1231)
Massachusetts (8100)
Michigan (314)
Minnesota (572)
Mississippi (4)
Missouri (82)
Montana (20)
Nebraska (11)
Nevada (122)
New Hampshire (60)
New Jersey (2691)
New Mexico (12)
New York (2896)
North Carolina (1316)
North Dakota (4)
Northern California (6208)
Ohio (293)
Oklahoma (14)
Oregon (16)
Pennsylvania (2295)
Puerto Rico (21)
Rhode Island (30)
South America (406)
South Carolina (78)
South Dakota (1)
Southern California (5138)
Tennessee (125)
Texas (2004)
United States (40016)
Utah (372)
Vermont (1)
Virginia (159)
Washington D.C. (38)
Washington State (955)
West Virginia (1)
Wisconsin (74)
Wyoming (1)
485,985 Results for "tagnos inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
TAGNOS Announces Sheila Minton as New Chief Executive Officer and the Launch of the TAGNOS Re-imagined Campaign
TAGNOS, an emerging Southern California Medical Technology software company, that empowers hospitals to orchestrate healthcare with increased situational intelligence, workflow optimizations, and improved asset utilization, is excited to announce the appointment of Sheila Minton as its new President and Chief Executive Officer
April 27, 2021
·
4 min read
Biotech Beach
TAGNOS Presents its Proximity Monitoring Solution
TAGNOS, a developer of workflow orchestration software for hospital operations, today announced its Proximity Monitoring Module designed to support the Zebra MotionWorks ® devices line.
August 25, 2020
·
2 min read
Biotech Beach
TAGNOS Receives Investment from Leading Technology Companies to Drive Healthcare Initiatives
Latest investment round includes Benhamou Global Ventures, Honeywell Ventures, Morpheus Ventures and Zebra Ventures to expand TAGNOS’ platform [20-May-2020] ALISO VIEJO, Calif. , May 20, 2020 /PRNewswire/ -- TAGNOS, a developer of workflow orchestration software for hospital operations, today announced investments from leading technology companies to expand and optimi
May 20, 2020
·
3 min read
Press Releases
Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
July 29, 2026
·
4 min read
Press Releases
Allumiqs Solutions Inc. and Allumiqs Corporation
September 15, 2026
·
1 min read
Job Trends
TAGNOS engages Amendola for strategic public relations and content marketing services
Amendola Communications, a nationally recognized, award-winning healthcare and health IT public relations and marketing firm, announced that TAGNOS has hired the agency to provide strategic PR and content marketing services.
October 22, 2019
·
3 min read
Press Releases
Carlsmed, Inc. Announces Chief Operating Officer Appointment
September 8, 2026
·
2 min read
Press Releases
Glucotrack, Inc. Announces Reverse Stock Split
August 27, 2026
·
6 min read
Press Releases
PostEra’s Fertility programs acquired by EMD Serono, Inc.
September 9, 2026
·
2 min read
Press Releases
Propanc Biopharma Positions PRP’s EMT-Reversal Mechanism as a Complementary Backbone to Emerging RAS Inhibitors from Revolution Medicines, Inc. and Erasca, Inc.
September 16, 2026
·
12 min read
1 of 48,599
Next
